Skip to main content

Table 1 The ITaLi-Q questionnaire

From: Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation

Domain

No. of items

Range

Description

Side effects

4

0–100

A higher score indicates a higher frequency of HBIG-related side effects

Side effects impact

3

0–100

A higher score indicates a higher impact of HBIG-related side effects on daily activities

Negative feelings

6

0–100

A higher score is associated with more negative, therapy-associated feelings (e.g., anxiety and fatigue)

Positive feelings

5

0–100

A higher score is associated with more positive, therapy-associated feelings (e.g., the perceived importance of one’s own health status)

Flexibility

8

0–100

A higher score corresponds to a more disturbing impact of therapy on daily-life flexibility (e.g., planning work or leisure)

Support

3

0–100

The higher the score, the greater is the level of support received to adhere to therapy (e.g., being reminded or being accompanied to outpatient follow-up visits)

Need for support

3

0–100

The higher the score, the greater is the perceived need for support to adhere to therapy

Satisfaction

5

0–100

A higher score indicates a higher degree of satisfaction related to HBIG therapy (e.g., overall satisfaction, satisfaction with the route of administration, and flexibility)